THERAPEUTIC PURGATION IN SKIN DISEASE

A CLINICAL STUDY TO EVALUATE THE EFFICACY OF VIRECHANA KARMA AND UDARDA PRASHAMANA MAHAKASHAYA IN SHEETAPITTA W.S.R TO URTICARIA - UDVISHEE

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/04/032978

Enrollment

Registered

2021-04-20

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L500- Allergic urticaria

Interventions

Intervention1: VIRECHANA KARMA WITH ERANDA TAIL AND TRIPHALA KWATH IN SHEETAPITTA: 30-50ML ERANDA TAIL WITH DOUBLE AMOUNT TRIPHALA KWATH Intervention2: UDARDA PRASHAMANA MAHAKASHAYA IN SHEETAPITTA: 5g

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS WITH CLASSICAL SYMPTOMS OF SHEETAPITTA viz. MANDALA UTSEDHA, TODA, DAHA, KANDU, CHHARDI. VIRECHANA ARHA PATIENTS

Exclusion criteria

Exclusion criteria: HISTORY OF ANAPHYLAXIS TO MODERN MEDICINE PRESCRIBED FOR URTICARIA. PATIENTS HAVING HISTORY OF ANY CHRONIC OR SYSTEMIC ILLNESS eg. HEART DISEASE, PARAPLASIA, TB, DIABETES, JAUNDICE, PREGNANT WOMEN, ANGIOEDEMA, LEPROSY, ECZEMA, FUNGAL INFECTION AND OTHER SKIN DISEASE.

Design outcomes

Primary

Measure	Time frame
RELIEF IN ITCHING AND RASHESTimepoint: 10 DAYS	—

Secondary

Measure	Time frame
NO RELAPSE OF SYMPTOMSTimepoint: 45 DAYS	—

Countries

India

Contacts

Public ContactDR SHUBHAM MAHESHWARI

GOVERNMENT P.G. AYURVEDA COLLEGE AND HOSPITAL, VARANASI

docshubham.mah@gmail.com8279749968

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026